Does the addition of discharge and change in NT-proBNP to known risk markers (ÉLAN-HF Score) improve the prediction of adverse events in patients hospitalised for ADHF?
The ÉLAN-HF Score, which incorporates discharge NT-proBNP and its change during hospitalization, improves the prediction of adverse events in patients with acute decompensated heart failure.
In patients hospitalised for ADHF, the addition of the discharge NT-proBNP values as well as the change in NT-proBNP to known risk markers, generates a relatively simple yet robust discharge risk score that importantly improves the prediction of adverse events.
Salah et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: